Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
Speaker 2: The Stock Movers Report, your roundup of companies making moves
Speaker 2: in the stock market, harnessing the power of Bloomberg data.
Speaker 3: Just take a look some of the stock movers on
Speaker 3: the day. Here, we're joined by Bloomers. Isabelle is about
Speaker 3: what are you looking at today?
Speaker 1: We're looking at Expedia ticker EXPE. But I want to
Speaker 1: throw an Instacart there, ticker art because both shares are
Speaker 1: in degree, with Expedia up by more than one percent
Speaker 1: Instacart up by more than four percent. That's after Jeffries
Speaker 1: upgraded both to buy the firms that a pullback on
Speaker 1: concerns of AI would mean that there's a good buying
Speaker 1: opportunity for both shares. So the two stocks are poised
Speaker 1: for upgrades to consentus estimates trade at notable evaluation discounts
Speaker 1: when adjusted for growth and unless exposed to geopolitical risks.
Speaker 1: So Expedia can continue to grow EPs by twenty percent
Speaker 1: per ADAM in the next three years and Intacart should
Speaker 1: see at least mid teens EPs growth going forward. So
Speaker 1: both those docks are seeing a huge jump today and
Speaker 1: they're green, and.
Speaker 3: They're green all right, let's talk about some M and
Speaker 3: A because it is Monday, m Anda.
Speaker 1: So this is Cisco ticker SYY. It's not the Cisco
Speaker 1: cis CEO. It's food company Sycso, yes, it's a food company.
Speaker 1: They supply food to restaurants, hospitals, and schools and have
Speaker 1: a market value of at least forty billion dollars, which
Speaker 1: is interesting because I don't think I've heard of the Cisco,
Speaker 1: but I guess it's one of those companies that are
Speaker 1: very valuable on the back end.
Speaker 3: You see the trucks all around, oh okay, and they
Speaker 3: just park and then then they walk and they deliver
Speaker 3: all the stuff. Okay, fronts within like two block radius,
Speaker 3: and I haven't heard the company they're buying those.
Speaker 1: Yes, I'm in the Grammy subway, so maybe that's why
Speaker 1: I don't see trucks, but yes, they're buying. So they
Speaker 1: agreed to buy privately held Jetro Restaurant for twenty nine
Speaker 1: point one billion dollars. So this is a cash and
Speaker 1: carry wholesaler and they serve around seven hundred thousand smaller
Speaker 1: restaurant owners and food service operators, so I guess it
Speaker 1: makes sense. It's kind of the same yeah.
Speaker 3: I feel like I've gone past the restaurant depot before
Speaker 3: in the past, so I think it's in Brooklyn if
Speaker 3: I'm remembering correctly. Well, what's interesting is this seller, this
Speaker 3: company that's being acquired privately held. Yeah, so here's a
Speaker 3: privately held company. He's going to get it. What is
Speaker 3: it twenty nine to thirty billion dollars pay day, Yeah.
Speaker 1: Thirty nine billion dollars. And the financing would help, would
Speaker 1: help them their credit ratings for once. Sisco said it's
Speaker 1: pausing its Sherby purchase program to prioritize reducing leverage following
Speaker 1: the acquisition. It's the largest cash and carry wholesaler in
Speaker 1: the US. That's jet Thro so again.
Speaker 3: And investment bankers. We got JP Morgan doing some financing.
Speaker 3: We got acquired advised by Goldman Sachs and TD Securities,
Speaker 3: and the seller's being advised by Evercorp. Again, another boutique
Speaker 3: investment bank getting paid big time of a big deal.
Speaker 1: And Jetro was founded in nineteen seventy six by Nathan Kirsch.
Speaker 1: He's a South African billionaire.
Speaker 3: Awesome, good for him.
Speaker 2: It's five sixty six Hamilton Avenue in Brooklyn.
Speaker 3: There's also one in Jersey City, Paul Okay on Amity Road.
Speaker 2: Yeah, in the industrial parts of town.
Speaker 3: Essentially got it one more. What do you got for us?
Speaker 1: Very Therapeutics Kicker VRDN stock is down more than thirty percent.
Speaker 1: It paired by some of those losses, but still it's
Speaker 1: down thirty four percent. This is again after clinical trial
Speaker 1: and active thyroid eye diseases. They announced those results, but
Speaker 1: it felt because the drug developer gave efficacy data from
Speaker 1: a late stage trial of its experiment, experimental therapy that
Speaker 1: fell short of expectations. Again, we talk about all these
Speaker 1: biotech companies and they swing big gains and big losses
Speaker 1: depending on the outcome. But for that, for now, it's
Speaker 1: not looking so great for them. We have Jefferys those
Speaker 1: still maintaining a by rating.
Speaker 2: So there's that the Stock mover's report from Bloomberg Radio.
Speaker 2: Check back with us throughout the day for the latest
Speaker 2: roundup of companies making news on Wall Street and for
Speaker 2: the latest market moving headlines. Listen to Bloomberg Radio Live,
Speaker 2: catch us on YouTube, Bloomberg dot com, and on Applecarplay
Speaker 2: and Android Auto with the Bloomberg Business app.